Dabalos, Vina Clyd P.
HRN: 10-98-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/01/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/01/2023
05/02/2023
IVT
500mg
Now Then Q8h X 3 Doses
S/P Primary CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes